Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic LeukemiaJohn C. Byrd, Susan O’Brien, Richard R. Furman et al.|New England Journal of Medicine|2013Cited by 2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic LeukemiaKathryn G. Roberts, Timothy P. Hughes, Naomi Winick et al.|New England Journal of Medicine|2014Cited by 1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemiaYu Liu, Charles G. Mullighan, John Easton et al.|Nature Genetics|2017Cited by 934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.Malcolm A. Smith, Richard S. Ungerleider, D Arthur et al.|Journal of Clinical Oncology|1996Cited by 914
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Kirk R. Schultz, Bruce M. Camitta, DJ Pullen et al.|Blood|2006Cited by 475